Scion Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Derabassi, Punjab, India, established in 2006.
2006 Derabassi, Punjab, India Struck Off
Last Updated:
Access Report
About Scion Pharmaceuticals Private Limited

Scion Pharmaceuticals Private Limited, a struck off private limited company, was established on 27 November 2006 in Derabassi, Punjab, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232PB2006PTC030713. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Vishal Krishan Kalia (Director), Poonam Singh (Director). Past directors included Vipin Kaushik. Its latest AGM occurred on 21 June 2013, with the balance sheet filed on 31 March 2013. It is based at 194/5 Adarsh Nagar, Derabassi, Punjab, 140507.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232PB2006PTC030713

  • Registration Number

    030713

  • Incorporation Date

    27 November 2006

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 19 Year, 2 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Scion Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Scion Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Scion Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Vishal Krishan Kalia Director 27 Nov 2006 Current
Poonam Singh Director 27 Nov 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 03 Jul 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Scion Pharmaceuticals.

Enhance accessibility to Scion Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Scion Pharmaceuticals revenue growth over time
Scion Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Scion Pharmaceuticals?

Unlock access to Scion Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Scion Pharmaceuticals?

Unlock and access historical data on people associated with Scion Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Scion Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scion Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Scion Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Scion Pharmaceuticals Private Limited last Annual general meeting of members was held on 21 Jun 2013 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Scion Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Chandigarh. was recorded as a recent event.

  • Director Appointment

    The activity Vishal Krishan Kalia was appointed as a Director was appointed as a Director on 27 Nov 2006 & has been associated with this company since 19 years 2 months . was completed.

  • Director Appointment

    Progress on Poonam Singh was appointed as a Director was appointed as a Director on 27 Nov 2006 & has been associated with this company since 19 years 2 months . was documented.

  • Company Incorporation

    Progress on Scion Pharmaceuticals Private Limited was registered on 27 Nov 2006 with Roc Chandigarh & aged 19 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Scion Pharmaceuticals Private Limited?

The CIN of Scion Pharmaceuticals Private Limited is U24232PB2006PTC030713.

Where is Scion Pharmaceuticals Private Limited headquartered?

Scion Pharmaceuticals Private Limited is headquartered at 194/5 Adarsh Nagar, Derabassi, Punjab, 140507.

When was Scion Pharmaceuticals Private Limited incorporated?

Scion Pharmaceuticals Private Limited was incorporated on 27 November 2006.

Who are the current directors of Scion Pharmaceuticals Private Limited?

The current directors of Scion Pharmaceuticals Private Limited are

What is the primary industry of Scion Pharmaceuticals Private Limited?

The primary industry of Scion Pharmaceuticals Private Limited is Chemicals.

Is Scion Pharmaceuticals Private Limited a listed company?

Scion Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Scion Pharmaceuticals Private Limited?

The authorized capital of Scion Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available